Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 4

2(40.0%)

Phase 2

1(20.0%)

5Total

N/A(2)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06608654Not ApplicableNot Yet Recruiting

Application of Electronic Endoscope in Fetal Distress

Role: collaborator

NCT06328049Phase 2Recruiting

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of NSCLC

Role: lead

NCT05420480Not ApplicableNot Yet Recruiting

Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy

Role: collaborator

NCT01561222Phase 4Unknown

Effect of Vitamin D Supplement on Osteoprotegin Expression and Disease Progression in Patients With Chronic Kidney Disease Stage 1 and 2

Role: lead

NCT01637844Phase 4Completed

Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV

Role: collaborator

All 5 trials loaded